NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Balk EM, Chung M, Chan JA, et al. Future Research Needs for Treatment of Obstructive Sleep Apnea: Identification of Future Research Needs From Comparative Effectiveness Review No. 32 [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2012 Feb. (Future Research Needs Papers, No. 12.)

Cover of Future Research Needs for Treatment of Obstructive Sleep Apnea

Future Research Needs for Treatment of Obstructive Sleep Apnea: Identification of Future Research Needs From Comparative Effectiveness Review No. 32 [Internet].

Show details

Appendix AAHRQ’s Effective Health Care Program Selection Criteria for New Research

1. Appropriateness1a. Represents a health care drug, intervention, device, technology, or health care system/setting available (or soon to be available) in the United States
1b. Relevant to 1013 enrollees (Medicare, Medicaid, S-CHIP, other federal health care programs)
1c. Represents one of the priority conditions designated by the Department of Health and Human Services (DHHS)
2. Importance2a. Represents a significant disease burden; large proportion or priority population
2b. Is of high public interest; affects health care decisionmaking, outcomes, or costs for a large proportion of the US population or for a priority population in particular
2c. Was nominated/strongly supported by one or more stakeholder groups
2d. Represents important uncertainty for decisionmakers
2e. Incorporates issues around both clinical benefits and potential clinical harms
2f. Represents important variation in clinical care, or controversy in what constitutes appropriate clinical care
2g. Represents high costs due to common use, to high unit costs, or to high associated costs to consumers, to patients, to health care systems, or to payers
3. Desirability of New Research/Duplication3. Would not be redundant (i.e., the proposed new research is not sufficiently researched by AHRQ or others, considering both completed and in-process research)
4. Potential Impact4a. Potential for significant health impact:

To improve health outcomes


To reduce significant variation in clinical practices known to be related to quality of care


To reduce unnecessary burden on those with health care problems

4b. Potential for significant economic impact:

To reduce unnecessary or excessive costs

4c. Potential for change:

The proposed topic exists within a clinical, consumer, or policymaking context that is amenable to evidence-based change


A product from the EHC program could be an appropriate vehicle

4d. Potential risk from inaction:

Unintended harms from lack of prioritization of a nominated topic

4e. Addresses inequities, vulnerable populations (including issues for patient subgroups)
4f. Addresses a topic that has clear implications for resolving important dilemmas in health and health care decisions made by one or more stakeholder groups
5. Capacity5a. Efficiency (i.e., considering the timing of the need for new evidence, it is likely that a result could be produced in a timely manner)
5b. Utilizes existing AHRQ resources or builds desired additional research capacity or decisional support for the EHC Program
5c. Costs associated with the likely study design are reasonable considering limited program resources
Bookshelf ID: NBK84515


  • PubReader
  • Print View
  • Cite this Page
  • PDF version of this title (791K)

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...